Non-Invasive Prenatal Test | VERAgene
Non-Invasive Prenatal Test (N.I.P.T) for aneuploidies, microdeletions and single gene diseases
VERAgene is the only non-invasive prenatal test that can simultaneously screen for aneuploidies, microdeletions and single gene diseases. The diseases screened by VERAgene are associated with moderate to severe phenotype with significant impact on the quality of life. By combining detection of aneuploidies and microdeletions with the screening of monogenic disorders, VERAgene provides a comprehensive solution to prospective parents.
WHAT SHOULD I ASK MY DOCTOR?
WHAT IS A NON-INVASIVE PRENATAL TEST (NIPT)?
It is a test that a pregnant woman can take to check for genetic conditions of the fetus before birth.
WHAT ARE GENETIC CONDITIONS?
Genetic conditions are caused by unwanted changes in the genome that happen during conception. Three types of genetic conditions are detected with the test:
- aneuploidies are genetic conditions that occur when a chromosome has an extra copy (trisomy) or is missing a copy (monosomy)
- microdeletions are genetic conditions caused by a small deletion in a specific region of a chromosome
- single gene diseases are genetic conditions caused by mutations in a gene
HOW CAN I TAKE THE VERAgene TEST?
BE AT LEAST 10 WEEKS PREGNANT
ASK YOUR DOCTOR ABOUT TAKING VERAgene
YOUR DOCTOR WILL COLLECT A BLOOD SAMPLE FROM YOU AND A BUCCAL SWAB FROM THE FATHER
THE SAMPLES WILL BE ANALYZED IN OUR LABORATORIES
THE TEST RESULTS WILL BE SENT TO YOUR DOCTOR IN 4-7 WORKING DAYS